TY  - GEN
AU  - Landry,M L
AU  - Stanat,S
AU  - Biron,K
AU  - Brambilla,D
AU  - Britt,W
AU  - Jokela,J
AU  - Chou,S
AU  - Drew,W L
AU  - Erice,A
AU  - Gilliam,B
AU  - Lurain,N
AU  - Manischewitz,J
AU  - Miner,R
AU  - Nokta,M
AU  - Reichelderfer,P
AU  - Spector,S
AU  - Weinberg,A
AU  - Yen-Lieberman,B
AU  - Crumpacker,C
TI  - A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates
SN  - 0066-4804
PY  - 2000///0403
KW  - Antiviral Agents
KW  - pharmacology
KW  - Cells, Cultured
KW  - Cytomegalovirus
KW  - drug effects
KW  - Cytomegalovirus Infections
KW  - virology
KW  - Fibroblasts
KW  - Foscarnet
KW  - Ganciclovir
KW  - Humans
KW  - Laboratories
KW  - standards
KW  - Microbial Sensitivity Tests
KW  - methods
KW  - Reproducibility of Results
KW  - Viral Plaque Assay
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1128/AAC.44.3.688-692.2000
ER  -